MedX Health Corp (MDX) Dipped -2.941% on Feb 15

February 15, 2018 - By Dolores Ford

Shares of MedX Health Corp (CVE:MDX) last traded at 0.165, representing a move of -2.941%, or -0.005 per share, on volume of 44,400 shares. After opening the trading day at 0.17, shares of MedX Health Corp traded in a close range. MedX Health Corp currently has a total float of 126.76 million shares and on average sees 328,703 shares exchange hands each day. The stock now has a 52-week low of 0.07 and high of 0.19.

Canada: S&P/TSX Index

The S&P/TSX Composite Index is the headline index of equities listed on Canada’s Toronto Stock Exchange (TSX).Its components are market capitalization-weighted and together the constituents of the index account for 70% of TSX market capitalization.
The S&P/TSX Composite replaced the TSE 300 Index.

Inclusion in the index

The S&P/TSX Composite has eligibility criteria that among others require that a candidate stock for inclusion in the index must be listed on the TSX and the company behind the stock must be incorporated under Canadian laws.

Being a market capitalization weighted index, components of S&P/TSX Composite must weigh at least 0.05% of the index. Additionally, index candidate must have traded at a minimum average price of C$1 over in the last three months and maintained a price of at least C$1 in the last three trading days of the month immediately before the index is rebalanced. Still on market capitalization, the index is also float adjusted, whereby restricted stocks, such as those held by company insiders and stock that don’t trade frequently such as those held by the government and venture capitalists are excluded.

Liquidity of a stock is another important consideration for inclusion in The S&P/TSX Composite. Though measure is taken so that no single stock dominates the movement of the index, a security must be liquid enough in terms of volume traded and dollar value. As such, the number of transactions in a security must be at least 0.025% of all the sum of trading volume of eligible securities. MedX Health Corp has relatively good liquidity.

The S&P/TSX Composite is the primary gauge of the performance of Canadian stocks, especially given its massive coverage of the country’s equity market. Besides being a benchmark, the S&P/TSX Composite is also an investible index.

The index has about 250 components representing a variety of sectors. Of the index’ sectors, Financials is the largest, accounting for 36% of the index. The second-largest sector in the index is Energy, representing 20% of the index. Canada has a booming energy sector backed by oil drilling, which explains the large position of Energy in S&P/TSX Composite. MedX Health Corp is a stock traded on the Canadian exchange.

Besides Financials and Energy, Materials, Industrials and Consumer Discretionary make the top 5 sectors in the index.
The S&P/TSX Composite is regularly rebalanced to remove constituents that fall short of eligibility requirement and replace them with newly eligible ones.

Index performance

S&P/TSX Index hit its lowest level on record of 217.50 points in February 1950. But the index reached an all-time high of 15657.63 points in September 2014, backed by soaring gold and crude oil prices. Excitement in the Canadian energy and commodities sectors also provided a boost to the Financials sector, thus lifting the index to the record high.

After a lull, investors are jostling for Canadian stocks again amid hopes of a bright future for commodities where prices will continue to strengthen after a long period of soft prices. The move by OPEC members to cap oil output to stabilize oil prices is also boosting investor appetite in Canadian stocks. The stability of the Canadian economy and the strong corporate governance standards are other reasons Canadian stock market is heating up with an influx of domestic and foreign retail investors. Professional analysts might be interested how this will affect MedX Health Corp.

More notable recent MedX Health Corp (CVE:MDX) news were published by: which released: “MedX Health Corp. Announces Proposed Private Placement” on January 08, 2018, also with their article: “MedX Health Corp. Announces Revenue Growth in its Third Quarter 2017 Results” published on November 29, 2017, published: “MedX Health Corp. announces Joint Venture Marketing Partnership with OncoTech LLC” on May 24, 2017. More interesting news about MedX Health Corp (CVE:MDX) were released by: and their article: “MedX Health Corp. Announces the Addition of Two Renowned International Skin …” published on November 13, 2017 as well as‘s news article titled: “MedX Health Corp. Announces Launch of Skin Scanning Service in the Netherlands” with publication date: November 29, 2017.

MedX Health Corp., a medical device company, develops, makes, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in North America, Europe, and Asia. The company has market cap of $20.92 million. The Company’s skin imaging products include SIMSYS-MoleMate, a skin imaging system for the non-invasive skin screening of moles and lesions. It currently has negative earnings. The company's phototherapy products comprise rehab laser console systems, dental laser console systems, acupuncture laser console systems, oralase portable laser probes, acupuncture portable laser probes, MedX home systems, and rehab portable lasers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: